Lone S. Friis

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

Alan K. Burnett, Nigel H. Russell, Robert K. Hills et al. · The Lancet Oncology · 2015 · 543 citations

Medicine, Hematology, Oncology +8

Hypomethylation and up-regulation of<i>PD-1</i>in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation

Andreas Due Ørskov, Marianne Bach Treppendahl, Anni Skovbo et al. · Oncotarget · 2015 · 186 citations · Full text

Medicine, Molecular Biology, Oncology +17

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> Mutations

Nigel H. Russell, Charlotte S. Wilhelm-Benartzi, Jad Othman et al. · Journal of Clinical Oncology · 2024 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

Martin Carré, Raphaël Porcher, Jürgen Finke et al. · Biology of Blood and Marrow Transplantation · 2019 · 39 citations · Full text

Medicine, Hematology, Oncology +16

C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Lia Minculescu, Brian Kornblit, Lone S. Friis et al. · Biology of Blood and Marrow Transplantation · 2017 · 16 citations · Full text

Veterinary Medicine, Hematology, Immunology +13